Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | TP53 | P04637 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18942232 | 0.99 | ALDH1A1 (0.50) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL14725203 | 0.96 | ALDH1A1 (0.53) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL20371234 | 0.86 | ALDH1A1 (0.39) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL14725207 | 0.86 | ALDH1A1 (0.43) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL7956106 | 0.84 | ALDH1A1 (0.45) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL14725210 | 0.82 | TSHR (0.52) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL14725209 | 0.82 | TSHR (0.52) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL7955961 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL20012998 | 0.76 | TSHR (0.36) | ALDH1A1TP53TSHRHIF1ACYP3A4 | |
| SCHEMBL1495871 | 0.76 | GRM2 (0.57) | ALDH1A1TP53TSHRHIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8092231-A | — | — | None | — | — | JP | disclosed |
| EP-3504283-B1 | SOLID HOMOGENEOUS AMORPHOUS HIGH HEAT EPOXY BLENDS, ARTICLES, AND USES THEREOF | SHPP GLOBAL TECH BV (NL) | 2021-04-07 | — | — | EP | disclosed |
| US-10870724-B2 | High heat monomers and methods of use thereof | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-12-22 | — | — | US | disclosed |
| US-20200263052-A1 | SOLID HOMOGENEOUS AMORPHOUS HIGH HEAT EPOXY BLENDS, ARTICLES, AND USES THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2020-08-20 | — | — | US | disclosed |
| EP-3640275-A1 | CURABLE EPOXY COMPOSITIONS AND CURED PRODUCTS THEREOF | SABIC Global Technologies B.V. (NL) | 2020-04-22 | — | — | EP | disclosed |
| US-10472467-B2 | Polymers having intrinsic microporosity including sub-units with troger's base and spirobisindane moieties | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-11-12 | — | — | US | disclosed |
| US-10465037-B2 | High heat monomers and methods of use thereof | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-11-05 | — | — | US | disclosed |
| US-20190322653-A1 | METHODS FOR SYNTHESIZING HIGH PURITY EPOXY COMPOUNDS AND PRODUCTS OBTAINED THEREFROM | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-10-24 | — | — | US | disclosed |
| US-20190211151-A1 | POLYMERS HAVING INTRINSIC MICROPOROSITY INCLUDING SUB-UNITS WITH TROGER'S BASE AND SPIROBISINDANE MOIETIES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-07-11 | — | — | US | disclosed |
| WO-2019035054-A1 | SOLID HOMOGENEOUS AMORPHOUS HIGH HEAT EPOXY BLENDS, ARTICLES, AND USES THEREOF | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-02-21 | — | — | WO | disclosed |
| WO-2018058116-A1 | HIGH HEAT AND HIGH TOUGHNESS EPOXY COMPOSITIONS, ARTICLES, AND USES THEREOF | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2018-03-29 | — | — | WO | disclosed |
| US-20170158806-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2017-06-08 | — | — | US | disclosed |
| US-20170158806-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2017-06-08 | — | — | US | disclosed |
| WO-2016014536-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-01-28 | — | — | WO | disclosed |
| US-6169158-B1 | HAVING A GLASS TRANSITION TEMPERATURE HIGHER THAN 20 DEGREES CELCIUS, BASED ON POLYFUNCTIONAL 1,1'-SPIROBIINDANS AND/OR 3,3',4,4'-TETRAHYDRO-2,2'-SPIROBI(2H-1-BENZOPYRAN); CURABLE, POWDER COATINGS | VANTICO, INC. | 2001-01-02 | — | — | US | disclosed |
| EP-1015440-A1 | POLYGLYCIDYL SPIROCOMPOUNDS AND THEIR USE IN EPOXY RESINS | Ciba SC Holding AG (CH) | 2000-07-05 | — | — | EP | disclosed |
| US-6080833-A | BIS(HYDROXYALKOXYLATED) 1,1'-SPIROBIINDAN POLYCARBONATES AND POLYESTERS POLYMERS AND CURABLE COMPOUNDS SUCH AS BIS(ACRYLATED ALKOXY)SPIROBIINDANS; ALSO POLYAMIDES AND POLYIMIDES CONTAINING SPIROBIINDAN GROUPS | MITSUI CHEMICALS, INC. (JP) | 2000-06-27 | — | — | US | disclosed |
| WO-1999003851-A1 | POLYGLYCIDYL SPIROCOMPOUNDS AND THEIR USE IN EPOXY RESINS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-01-28 | — | — | WO | disclosed |
| EP-0822545-A2 | Optical component and spirobiindan polymer therefor | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1998-02-04 | — | — | EP | disclosed |
| JP-H0892231-A | SPIROBIINDAN DIGLYCIDYL ETHER AND ITS PRODUCTION | MITSUI TOATSU CHEM INC | 1996-04-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10870724-B2 | High heat monomers and methods of use thereof | HSP90AA1, HSP90AB1, EPHX2 | ALDH1A1 318/4885TP53 710/4885TSHR 4879/4885 |
| US-20170158806-A1 | HIGH HEAT MONOMERS AND METHODS OF USE THEREOF | HSP90AA1, HSP90AB1, EPHX2 | ALDH1A1 318/4885TP53 710/4885TSHR 4879/4885 |
| US-10465037-B2 | High heat monomers and methods of use thereof | HSP90AA1, HSP90AB2P, HSP90AB1 | ALDH1A1 295/4885TP53 794/4885TSHR 4878/4885 |
| US-20190322653-A1 | METHODS FOR SYNTHESIZING HIGH PURITY EPOXY COMPOUNDS AND PRODUCTS OBTAINED THEREFROM | EPHX2, EPHX1, CYP2F1 | ALDH1A1 138/4885TP53 3230/4885TSHR 4683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.